Aethlon Medical (AEMD) EBT Margin (2011 - 2023)
Aethlon Medical (AEMD) posted EBT Margin of 5657.68% for Q1 2023, up 97.6% on a QoQ basis from 235404.83% in Q1 2022, and up 22974716.0% year-over-year from N/an in Q1 2022.
Aethlon Medical (AEMD) EBT Margin (2011 - 2023) Analysis & Trends
Aethlon Medical's EBT Margin history runs 13 years deep, the most recent figure standing at 5657.68% for Q1 2023.
- Quarterly EBT Margin rose 22974716.0% year-over-year to 5657.68% in Q1 2023, while the trailing twelve-month figure through Mar 2023 was 7298.29% (up 622639.0% YoY) and the FY2023 annual result came in at 7298.22%, up 545343.0% from the prior year.
- EBT Margin was 5657.68% for Q1 2023 at Aethlon Medical, up from 235404.83% in the prior quarter.
- Across five years, EBT Margin topped out at 213.45% in Q4 2019 and bottomed at 235404.83% in Q1 2022.
- A 5-year average of 25135.38% and a median of 2851.07% in 2021 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin sank 22878504 bps — and 2023, when it soared 22974716 bps.
- Aethlon Medical's EBT Margin stood at 213.45% in 2019, then plunged by 144 bps to 520.17% in 2020, then plunged by 2739 bps to 14768.63% in 2021, then plunged by 1494 bps to 235404.83% in 2022, then jumped by 98 bps to 5657.68% in 2023.
- Business Quant data shows AEMD's EBT Margin at 5657.68% in Q1 2023, 235404.83% in Q1 2022, and 14768.63% in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Aethlon Medical | 7,224.60 | 7,224.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -5,657.68% |
| Mar 31, 2022 | -235,404.83% |
| Dec 31, 2021 | -14,768.63% |
| Sep 30, 2021 | -1,984.45% |
| Jun 30, 2021 | -2,851.07% |
| Mar 31, 2021 | -6,619.79% |
| Dec 31, 2020 | -520.17% |
| Mar 31, 2020 | -863.63% |
| Dec 31, 2019 | -213.45% |
| Jun 30, 2019 | -5,460.55% |
| Mar 31, 2019 | -2,144.92% |
| Jun 30, 2018 | -770.18% |
| Mar 31, 2018 | -1,772.67% |
| Dec 31, 2017 | -1,630.12% |
| Sep 30, 2016 | -584.16% |
| Jun 30, 2016 | -46,095.99% |
| Mar 31, 2016 | -613.77% |
| Dec 31, 2015 | -409.60% |
| Sep 30, 2015 | -664.45% |
| Jun 30, 2015 | -632.00% |